BNTX - BioNTech SE
101.95
-1.850 -1.815%
Share volume: 668,982
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$103.80
-1.85
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 05-06-2024 | |
| Assets | ||
| Total Assets | 24.038 B | |
| Current Assets | 19.736 B | |
| Inventories | 373.036 M | |
| Other Current Assets | 7.897 B | |
| Short Term Investments | 7.897 B | |
| Total Receivables | 1.771 B | |
| Current Cash | 9.695 B | |
| Total Non-current Assets | 4.301 B | |
| Property Plant Equipment | 866.816 M | |
| Other Assets | 2.051 B | |
| Intangible Assets | 887.445 M | |
| Goodwill | 398.200 M | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 24.038 B | |
| Total liabilities | 2.472 B | |
| Total current liabilities | 1.734 B | |
| Accounts Payable | 322.707 M | |
| Other liabilities | 473.261 M | |
| Current long term debt | 33.804 M | |
| Long term debt | 221.402 M | |
| Other liabilities | 473.261 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 21.566 B | |
| Common stock | 240.534 M | |
| Retained earnings | 21.004 B |